成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Hormones and the Endocrine System>Pancreatic hormone and blood sugar regulation>Semaglutide
Semaglutide
  • Semaglutide
  • Semaglutide

Semaglutide NEW

Price Get Latest Price
Package 1g 10g 1000g
Min. Order: 1g
Supply Ability: 20kg
Update Time: 2024-12-18

Product Details

Product Name: Semaglutide CAS No.: 910463-68-2
Min. Order: 1g Purity: 99.5% HPLC
Supply Ability: 20kg Release date: 2024/12/18

Semaglutide Overview

Semaglutide, an amino-acid peptide, is used in the treatment of type 2 diabetes and as an anti-obesity agent for weight management. Similar to the hormone GLP-1, it functions as a receptor agonist, enhancing insulin production and inhibiting glucagon release. It improves glycemic control in adults with type 2 diabetes and aids in long-term weight management in obese or overweight adults with weight-related comorbidities. Semaglutide also reduces food intake by decreasing appetite and delaying gastric emptying, contributing to body fat reduction.

Product Details

· Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLRGRG

· Molecular Formula: C187H291N45O59

· Molecular Weight: 4113.64 g/mol

· PubChem CID: 56843331

· CAS Number: 910463-68-2

Research Highlights

1. Long-term Weight Management: In the STEP 5 trial, semaglutide led to substantial and sustained weight loss over 104 weeks in adults with obesity or overweight with comorbidities, averaging a 15.2% reduction from baseline.

2. Cardiometabolic Health: Contributes to improvements in cardiometabolic risk factors like reduced waist circumference and lower systolic blood pressure, indicating potential for reducing cardiovascular event risks.

3. Treatment of Type 2 Diabetes: Approved for type 2 diabetes treatment due to its effectiveness in increasing insulin production and inhibiting glucagon production, addressing key aspects of diabetes management.

4. Obesity with Comorbidities: The higher-dose formulation is indicated for weight management in adults with obesity or being overweight with weight-related comorbidities, broadening its application beyond diabetes care.

· Important Notices:

· This product is sold for scientific research purposes only.



Company Profile Introduction

You may like

Recommended supplier

Product name Price   Suppliers Update time
$5.00/1Box
VIP1Y
Hebei Jiafan Trading Company Limited
2024-12-23
$0.00/1kg
VIP1Y
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2024-12-17
$22.86/1Box
VIP1Y
American HealthyMorph LLC
2024-12-13
$20.00/1kg
VIP1Y
Shaanxi Franta Biotechnology Co., Ltd
2024-12-06
$0.00/100MG
VIP3Y
HangZhou RunYan Pharma Technology Co.,LTD.
2024-11-25
$1.00/1gram
VIP6Y
Shanghai Longyu Biotechnology Co., Ltd.
2024-11-21
$213.00/1mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-20
$60.00/1Box
Hebei Weimiao Import and Export Trade Co., Ltd.
2024-11-18
$50.00/1box
VIP1Y
Huaian Banting Trading Co., Ltd.
2024-11-11
$10.00/1g
VIP1Y
BJV BIOTECH LTD
2024-11-11
  • Since: 2011-01-12
  • Address: No.518, Nanbin Road, Zhangzhou Economic Development Zone. Fujian, China
INQUIRY